LFST (LifeStance Health Group) Total Stockholders Equity: $1,477 Mil (As of Mar. 2026)


LFST LifeStance Health Group Inc LFST
56 GF Score
Price $10.72
GF Value $8.24
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is LifeStance Health Group Total Stockholders Equity?

LifeStance Health Group LFST +3.58% 56 Total Stockholders Equity is $1,477 Mil as of Mar. 2026. GuruFocus rates LFST with a GF Score™ of 56/100 and a GF Value™ of $8.24 (Modestly Overvalued). The stock has 5 warning signs investors should review.

LifeStance Health Group's Total Stockholders Equity for the quarter that ended in Mar. 2026 was $1,477 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. LifeStance Health Group's Book Value per Share for the quarter that ended in Mar. 2026 was $3.81. The ratio of a company's debt over equity can be used to measure how leveraged this company is. LifeStance Health Group's Debt-to-Equity for the quarter that ended in Mar. 2026 was 0.31.


LifeStance Health Group  (NAS:LFST) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

LifeStance Health Group's Book Value per Share for the quarter that ended in Mar. 2026 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

LifeStance Health Group's Debt-to-Equity for the quarter that ended in Mar. 2026 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LifeStance Health Group Total Stockholders Equity Related Terms


LifeStance Health Group Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for LifeStance Health Group's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LifeStance Health Group Total Stockholders Equity Chart

LifeStance Health Group Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial 1,545.03 1,518.72 1,428.93 1,446.29 1,521.02

LifeStance Health Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,457.10 1,473.92 1,492.74 1,521.02 1,477.42
LFST
56GF Score
LifeStance Health Group Inc LFST
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of $1,477 Mil mean?
LifeStance Health Group (LFST) has a Total Stockholders Equity of $1,477 Mil as of Mar. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for LifeStance Health Group and its competitors.
Is LifeStance Health Group's Total Stockholders Equity too high?
LifeStance Health Group's current Total Stockholders Equity is $1,477 Mil. Overall, LifeStance Health Group has a GF Score™ of 56/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does LifeStance Health Group's Total Stockholders Equity compare to CON and BKD?
LifeStance Health Group's Total Stockholders Equity of $1,477 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Healthcare Providers & Services company?
A good Total Stockholders Equity depends on the Healthcare Providers & Services industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for LifeStance Health Group and its competitors. LifeStance Health Group's current Total Stockholders Equity is $1,477 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeStance Health Group stock overvalued right now?
Based on GuruFocus' analysis, LifeStance Health Group (LFST) is currently considered Modestly Overvalued. The stock's GF Value™ is $8.24, compared to a current price of $10.72 — trading 30.1% above its estimated fair value. The current Total Stockholders Equity is $1,477 Mil. LifeStance Health Group's overall GF Score™ is 56/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For LifeStance Health Group (LFST), the current Total Stockholders Equity is $1,477 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is LifeStance Health Group (LFST) Overvalued in 2026?

Based on GuruFocus' analysis, LifeStance Health Group stock appears to be overvalued. The current stock price of $10.72 is trading 30.1% above its estimated GF Value™ of $8.24. GuruFocus considers LifeStance Health Group to be Modestly Overvalued.

Key valuation signals for LFST:

  • Total Stockholders Equity: $1,477 Mil
  • GF Value™: $8.24 vs. price of $10.72 (30.1% above fair value)
  • GF Score™: 56/100 with 5 warning signs

No single metric tells the full story. See the LFST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


LifeStance Health Group Business Description

Address 4800 North Scottsdale Road, Suite 2500, Scottsdale, AZ, USA, 85251
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
56GF Score

Get the complete analysis for LFST

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.72
Price
$8.24
GF Value